Psych News Alert | donanemab

FDA Approves Donanemab Infusions for Treatment of Early Alzheimer’s Disease

Jul 5, 2024 12:00:00 AM

Donanemab Significantly Slows Progression of Alzheimer’s Disease, Study Finds

Jul 18, 2023 12:00:00 AM